| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/18/2005 | US20050180950 Chemically modified TNF-alpha |
| 08/18/2005 | DE102004004034A1 Zwiebelextrakte Onion extracts |
| 08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
| 08/18/2005 | CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 08/18/2005 | CA2554975A1 Methods of preventing and treating sars using low ph respiratory tract compositions |
| 08/18/2005 | CA2554683A1 Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers |
| 08/18/2005 | CA2554671A1 Chemokine ccr5 receptor modulators |
| 08/18/2005 | CA2554634A1 Compositions, methods and uses for a novel family of peptides |
| 08/18/2005 | CA2553038A1 Compositions substantially free of galactomannan containing piperacillin and tazobactam |
| 08/18/2005 | CA2549083A1 Anti-viral pharmaceutical compositions |
| 08/17/2005 | EP1564219A1 N-terminally monopegylated polypeptides and process for their preparation |
| 08/17/2005 | EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 08/17/2005 | EP1563840A1 Dengue virus infection inhibitor |
| 08/17/2005 | EP1563834A1 Hollow nanoparticles of protein and drug using the same |
| 08/17/2005 | EP1563062A1 Antimicrobial activity of antibodies producing reactive oxygen species |
| 08/17/2005 | EP1562981A2 Ligands |
| 08/17/2005 | EP1562966A1 SUBSTITUTED 9A-N-[N'-(BENZENESULFONYL)CARBAMOYL-Y-AMINOPROPYL] AND 9a-N-[N'-(B-CYANEOTHYL)-N'-(BENZENESULFONYL)CARBAMOYL-Y-AMINOPROPYL] DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9A-AZA-9A-HOMOERITHROMYCIN A AND 5-0-DESOSAMINYL-9-DEOXO-9-DIHYDRO-9A-AZA-HOMOERITHRONOLIDE A |
| 08/17/2005 | EP1562942A1 Amorphous moxifloxacin hydrochloride |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562920A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 08/17/2005 | EP1562913A1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 08/17/2005 | EP1562628A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 08/17/2005 | EP1562615A1 Oral and dental composition |
| 08/17/2005 | EP1562598A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 08/17/2005 | EP1562580A1 Intermediates for aromatic polyketides as selective anticancer and antiviral agents |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1485385B1 Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them |
| 08/17/2005 | EP1436380B1 Composition comprising a lactobacillus strain and uses thereof |
| 08/17/2005 | EP1351680B8 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity |
| 08/17/2005 | EP1340750B1 Amide derivatives |
| 08/17/2005 | EP1315496B1 The treatment of inflammatory disorders |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 08/17/2005 | EP1194141B1 Antiviral therapy |
| 08/17/2005 | EP1185712B1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
| 08/17/2005 | EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 08/17/2005 | EP0835128B1 Use of il-11 to treat inflammation |
| 08/17/2005 | CN1656237A Antiviral inhibition of capsid proteins |
| 08/17/2005 | CN1656215A Process for producing cytotoxic lymphocyte |
| 08/17/2005 | CN1656212A Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the HIV virus reverse transcriptase |
| 08/17/2005 | CN1656116A Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the HPV-16 virus |
| 08/17/2005 | CN1656113A Sialic combined immunoglobulin like agglutinin inhibitors |
| 08/17/2005 | CN1656109A Non nucleoside reverse transcriptase inhibitors |
| 08/17/2005 | CN1656101A Esters in position 20 of camptothecins |
| 08/17/2005 | CN1656100A Camptothecins with a modified lactone ring |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
| 08/17/2005 | CN1656083A Novel heterocyclic compounds having antibacterial activity; process for their preparation and pharmaceutical compositions containing them |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656070A Melanocortin receptor ligands |
| 08/17/2005 | CN1656067A New salts |
| 08/17/2005 | CN1655833A Medical devices containing rapamycin analogs |
| 08/17/2005 | CN1655826A Non-viral gene delivery system |
| 08/17/2005 | CN1655825A Non-viral gene delivery system |
| 08/17/2005 | CN1655817A Oxygenating agents for enhancing host responses to microbial infections |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655812A Anitmicrobial polymer conjugates |
| 08/17/2005 | CN1655811A 组合物及其治疗用途 The composition and therapeutic use |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655807A Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition |
| 08/17/2005 | CN1655791A Peritoneal dialysis solution with taurolidine |
| 08/17/2005 | CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 08/17/2005 | CN1655785A N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 08/17/2005 | CN1655783A Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 08/17/2005 | CN1655781A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 08/17/2005 | CN1655778A Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus |
| 08/17/2005 | CN1655775A Use of 20-HETE synthesizing enzyme inhibitors as therapy for cerebral vascular disease |
| 08/17/2005 | CN1655774A Bis-aromatic alkanols |
| 08/17/2005 | CN1655773A Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/17/2005 | CN1655770A Chewable soft capsule |
| 08/17/2005 | CN1655768A Oral dosage form for controlled drug release |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1655675A Combination therapy using trefoil peptides |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654653A Novel natural antibacterial peptide HKABF and its preparation and application |
| 08/17/2005 | CN1654651A Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 08/17/2005 | CN1654477A Process for preparing transfer factor-heating method |
| 08/17/2005 | CN1654475A Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 08/17/2005 | CN1654474A 重组幽门螺杆菌热休克蛋白60 Recombinant H. pylori heat shock protein 60 |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1654472A Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/17/2005 | CN1654471A Recombinant helicobacter pylori blood group antigen adhesin |
| 08/17/2005 | CN1654470A Recombinant helicobacter pylori outer-membrane protein 15 |
| 08/17/2005 | CN1654073A Paster for treating tinea unguium |
| 08/17/2005 | CN1654072A Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 08/17/2005 | CN1654055A AIDS-treating Chinese medicinal powder with immune function improving function |
| 08/17/2005 | CN1654054A Chinese herbal prescription for treating AIDS |
| 08/17/2005 | CN1654051A Chinese medicinal tonifying wine capable of chest oppression soothing, qi regulating, stomach regulating, tendons relaxing and activating functions |
| 08/17/2005 | CN1654049A Chinese medicinal tonifying wine for preventing and treating pestilence, cholera, abdominal pain and stomach stuff |
| 08/17/2005 | CN1654047A AIDS-treating Chinese drug for expelling toxin |
| 08/17/2005 | CN1654046A Chinese drug for treating infantile convulsion, fever, cough and diarrhea due to bird flu virus infection |
| 08/17/2005 | CN1654045A Chinese medicinal prescription for treating large-scale pestilence of chicken, duck, goose, dog and pig |
| 08/17/2005 | CN1654043A Method for preparing pure Chinese medicinal single prescription aqua agent and use thereof |
| 08/17/2005 | CN1654038A Buccal tablet of tea polyphenol for preventing and treating colds and resisting inflammation and preparation thereof |
| 08/17/2005 | CN1215167C Helicobacter pylori live vaccine |
| 08/17/2005 | CN1215082C Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses |
| 08/17/2005 | CN1215077C Method for preparing and isolating 9-deoxo-9 (Z)-hydroxyiminoerythromycin A |